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feasible in 40 (83%) pts.
TIE TEE PI. CATH
MIG(mmH9) 55.9* 62.4
mGlmmHg) 41.8* 45.8
LVOT area Icm2) 39 4.0'
AVAlcm2) 0.91* 0.90*' 0.88* 0.89
Correlations between Doppler- and CATH-derived gradients were excellent
either simultaneously or not (MIG = 0.96, SEE = 6, p < 0.001; mG, r = 0.96,
SEE = 4, P < 0.001; AVA, r 0.92, SEE 0.18, P < 0.0011. PL-AVA and CATH
correlated less closely (r 0.78, SEE 0.22, P < 0.001). In conclusion: 1) TEE-
LVOT is measurable in 100% of AS pts and can be accurately used as an
alternative when TIE-LVOT is suboptimal; 2) AVA-PL is measurable in 83%
of AS pts and less accurate than the CE; and 3) Doppler-derived gradients
do not need to be done simultaneously to accurately reflect CATH as long
as Doppler is performed in dose temporal relation and by an experienced
sonographer.
*, comparison with CATH p < 0.001, t, comparison with TIE p < 0.001)
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Prognostic Value of Ultra-Low Frequency Heart
Rate Variability in Chronic Aortic Regurgitation
Lisa A. Freed, Kenneth M. Stein, Jeffrey S. Borer, Clare Hochreiter, PhylliS Supino,
Richard B. Devereux, Paul Kligfield. The New York Hospital- Cornell Medical Cenrer,
New York, NY
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(1) For any anatomic area, Cc was larger for the longer tapered dome,
which allows more gradual flow convergence proximal to the limiting ori-
fice (less distal contraction). (2) For each funnel shape, Cc increased with
increasing orifice to proximal funnel size (more tube-like). Conclusions: Cc,
which can alter net head loss, is importantly affected by the variations in
leaflet geometry seen in patients. Echo stereolithography can allow us to
address such uniquely 3D questions.
Effects of Facilitation on Human AV Nodal Fast
and Slow Pathways
Sotalol in the Treatment of Resistant
Supraventricular Arrhythmias
Paul E. Nolan, Frank I. Marcus, d,I-Sotalol Compassionate Use Investigators.
University ofArizona, Tucson, AZ
D,L-Sotalol is newly approved for the treatment of life-threatening ventricu-
lar arrhythmias. Several small studies suggest that d,l-sotalol is also useful in
the management of supraventricular arrhythmias (SVA). To determine the ef-
ficacy and safety of d,l-sotalol in the treatment of resistant SVA, data from the
d,l-sota/o/ compassionate use database were examined. One hundred fifty-
four patients, 53 ± 15.3 years of age with SVA, who had failed an average of
5.2 ± 1.8 antiarrhythmics, were enrolled. Ninety-four (61 %) patients had AF,
22 (14%) WPW, 20 (13%) SVT, 12 (8%) AFL and 6 (4%) AVNRI Forty-three
patients (28%1 had d,l-sotalol discontinued during the acute phase chiefly
due to lack of response (n = 23) or adverse effects (n = 15). One hundred
eleven patients (72%) entered into the long-term phase. After 6, 12, 18 and
27 months of treatment, the probability of no recurrence of SVA was 61 %,
54%, 51 % and 36%, respectively. Also at a mean duration of therapy with
d,l-sotalol of 8.7 months and compared to baseline. the percent of patients
having palpitations or dizziness decreased from 92% to 74% (p = 0.005) and
from 56% to 40% (p = 0.0231, respectively. During long-term treatment, 48
of 111 (43%) patients discontinued d,l-sota/ol chiefly because of loss of ef-
ficacy (n = 30) or adverse effects (n = 9). The probability of continuing with
d,l-sotalol at 6, 12, 18 and 27 months was 69%, 58%, 56% and 49%, respec-
tively. New clinical events attributable to d,l-sotalol were mostly cardiovas-
cular (palpitations, bradycardia, chest pain and dyspnea) or central nervous
effects (fatigue, dizziness and sleep problems). Only 4 (2.6%) of the 154 pa-
tients experienced proarrhythmia, of which 3 (1.9%) episodes were torsades
de pointes: 2 in the acute phase and 1 in the long-term phase. None of these
episodes were fatal.
Conclusion: Estimates of arrhythmia and symptom recurrence in addition
to safety data suggest that d,l-sotalol is efficacious in the treatment of drug-
refractory SVA.
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Role of Biplane Transesophageal
Echocardiography In Assessing Severity of Aortic
Stenosis: Planimetry vs. Continuity Equation
Miguel Zabalgoltia, Avanindra Jain, Rex Outtrim, Edward Sako, Robert A. O'Rourke.
The University of Texas Health Science Center at San Antonio, San Antonio, TX
Ultra-low frequency heart rate variability can predict progression to valve
surgery or cardiac death in patients with mitral regurgitation, but its prog-
nostic value in patients with chronic pure aortic regurgitation has not been
defined. We examined heart rate variability in 46 asymptomatic or minimally
symptomatic patients with chronic severe aortic regurgitation and no evi-
dent coronary disease, who underwent ambulatory electrocardiography as
part of a prospective study of the natural history of regurgitant valvular dis-
eases. At entry, all patients were in sinus rhythm, and were NYHA functional
class I or early II, with left ventricular ejection fraction :;:45%, left ventricular
dimension in diastole (LVIDd) :;:5.5 cm in females, LVIDd :;:5.9 cm in males.
Endpoints were progression to aortic valve replacement (n = 19) or cardiac
death (n = 1). A measure of ultra-low frequency heart rate variability, SDANN,
was calculated as the standard deviation of the 5 minute mean RR intervals
over 24 hours. Based on a median SDANN of 144 msec as a partition value,
event-free survival in patients with SDANN <144 msec (n = 23) was com-
pared to that in patients with SDANN :;:144 msec (n = 23) using the log rank
test, as shown in the figure. The average annual risk of endpoint events was
10.2% for SDANN <144 msec and 2.6% for SDANN :;:144 msec (p = 0.003).
Conclusion: Ultra-low frequency heart rate variability measured as SDANN
strongly concentrates risk of progression to valve surgery or cardiac death
in asymptomatic and minimally symptomatic patients with chronic pure aor-
tic regurgitation.
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Accurate calculation of aortic valve area (AVA) by the continuity equation
(CE): A1 . Vl N2' relies on an optimal 2D imaging of Al (LV outflow tract
[LVOTI diameter/2 . 1r. To evaluate: 1) whether transesophageal echo (TIE)-
LVOT can be utilized as an alternative to transthoracic echo (TIE), and 2) to
compare the AVA measured by direct TEE planimetry (PL) in the same popu-
lation, 48 pts with suspected aortic stenosis (AS) underwent TIE simultane-
ously (24 pts) or within 7 days (24 pts) prior to catheterization (CATH). When
simultaneously, Doppler signals were superimposed to CATH pressure trac-
ings. Biplane TEE was done within 48-hrs of CATH. AVA by PL, Doppler-
derived maximal instantaneous gradient (MIG), mean gradient (mG) and AVA
using LVOT area from TTE and from TEE were compared with CATH. Results:
TTE-LVOTwas suboptimal in 9 (19%) pts, and in none byTEE. AVA by PL was
Gregory A. Kidwell, Gerard J. Fahy. The Cleveland Clinic Foundation, Cleveland, Ohio
The effect of facilitation on AV nodal function was studied in twelve patients
before and after radiofrequency ablation (RFA) of the slow pathway. AV nodal
recovery time (H 1A2 or H2A3) was plotted against AV nodal conduction time(A2H2 or A3H3) for test intervals from control and facilitation protocols re-
spectively (see figure). The mean Al A2 for the facilitation protocol was 363 ±
15 ms. The minimal recovery time (RT), functional refractory period (FRP) and
conduction time (CT) of both the fast and slow pathways were determined.
The effect of facilitation on CT was assessed at the minimal RT obtained
during control testing. Results:
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Fast Pathway Slow Pathway
Pre-RFA RT FRP CT RT FRP CT
Control 271 ± 22 430 ± 30 161 ± 12 198 ± 14 462 ± 22 273 ± 15
Facilitation 228 ± 25 391 ± 17 132 ± 9 131 ± 15 421 ± 20 231 ± 11
P value 0.003 00007 0.0006 <0.0001 <00001 0.0006
Fast and slow pathway properties were enhanced by facilitation in all pa-
tients. Facilitation significantly decreased the minimal RT. FRP and CT of both
pathways (see table). The window of test impulses over which slow pathway
conduction was observed was significantly increased by the facilitation pro-
tocol (81 ± 17 vs 110 ± 23 ms. p = 0.04) and in four patients facilitation
unmasked dual AV nodal physiology and resulted in AVNRT induction. The
effect of facilitation on fast pathway CT persisted after RFA but changes in
minimum RT and FRP were not observed. Conclusions:
1) Facilitation enhances AV nodal fast and slow pathway function and pro-
motes the induction of AVNRT.
21 The effects of facilitation on fast pathway function are attenuated fol-
lowing slow pathway ablation.
Cyclical Variation in the Occurrence of
Paroxysmal Supraventricular Tachycardia in
Female Patients
Day7 Day 14 Day 21 Day 28
Heart Rate 72± 9 73 ± 13 76 ± 9 76 ± 14
No episodes 28 25 36 49'
Duration 12 ± 14 12 ± 11 21 ± 14 27 ± 11'
Class Lawn >2 3 3 2 9'
Decreased heart rate variability. a manifestation of reduced tonic vagal ac-
tivity. has been reported following radiofrequency catheter ablation (RFCA)
for AV nodal reentrant tachycardia (AVNRT). Disruption of parasympathetic
fibers in the posteroseptal region is the proposed mechanism. Baroreflex
sensitivity (BRS). an index of reflex vagal activity. has not been evaluated in
patients with AVNRT. We studied BRS prior to and immediately following
RFCA in 20 patients with AVNRT(age 13-65 years, mean 42; 15 females. 5
males). Fourteen patients with atrioventricular reentrant tachycardia (AVRT)
and free wall accessory pathways (age 14-46 years. mean 25; 6 females. 8
males) were evaluated as controls (RFCA site far from posteroseptal region I.
BRS (msec/mmHg) was assessed with continuous femoral artery blood pres-
sure (BP) and ECG recordings during the bolus administration of phenyle-
phrine (400 I-'g). BRS was calculated as the slope of the change in cycle
length vs the change in systolic BP during the first sustained rise in BP. At
baseline. prior to RFCA. mean BRS for patients with AVNRTwas significantly
less than for patients with AVRT (8.3 ± 5.9 vs 22.1 ± 10.3; P < 0.0002). This
difference remained significant when controlled for age (p < 0.0002) and
male gender (p < 0.0003). but not for female gender (p < 0.09). Following
RFCA there was no significant change in BRS for patients with AVNRT (9.3
± 7.6) or AVRT (17.3 ± 9.6) compared to pre-RFCA values. This comparison
remained insignificant when controlled for age or gender. These results sug-
gest that in the baseline state, patients with AVNRT have lower reflex vagal
actiVity than patients with AVRT. Reduced reflex vagal activity may contribute
to the development of sustained AVNRT in patients with dual AV nodal phys-
iology. RFCA did not alter BRS in either patient group.
'p < 0.05 Day 28 compared to day7
A significant positive correlation was found between plasma concentra-
tions of progesterone and number and duration of SVT (r2 = 0.81. P < 0.05
and r2 = 0.78. P < 0.05, respectively) while a significant inverse correlation
was found between plasma concentrations of estradiol 17fJ and number an
duration of SVT (r2 = -0.91. P < 0.05. r2 = 0.67, P < 0.05. respectively).
In conclusion female pts with SVT and normal menses exhibit a cyclical
variation in the occurrence of the episodes of SVT with their menses and a
close correlation between the episodes of SVT and the plasma concentra-
tions of ovarian hormones. These data suggest that changes in plasma levels
of ovarian hormones (and their balance) may be of importance in determining
episodes of SVT in such patients.
The role of autonomic tone on antegrade atrioventricular nodal (AVN) con-
Giuseppe M.C. Rosano, Piotr Ponikowski, Eugenio Martuscelli, Fabio De Luca,
Filippo Leonardo. Francesco Romeo. University of Reggio Calabria, Rome and
Catama, Italy
The aim of the present study was to assess the presence of cyclical vari-
ations of episodes of supraventricular tachycardia (SVT) in female patients
(pts) and to correlate their occurrence with the cyclical variation in the plasma
levels of ovarian hormones. The study population included 26 (mean age 36
± 8) female pts with episodes of SVT. included in the study were those with
at least 3 episodes of SVT in 2 consecutive ambUlatory ECG monitoring and
regular menses (AEM). Thirteen patients (mean age 32 ± 6) met the study
criteria and entered the study. Pts underwent 48 hour AEM and determina-
tion of plasma concentrations of estradiol 17fJ and progesterone on day 7,
14,21 and 28 of their menstrual cycle.
Autonomic Effects on Nodal Conduction as
Assessed Before and After Radiofrequency
Current Ablation in Patients with Atrioventricular
Nodal Reentrant Tachycardia
Matthias Antz, Riccardo Cappato, Joachim Hebe. Christian Weiss.
Thomas Meinertz. Karl-Heinz Kuck. University Hospital Eppendorf, and St. Georg
Hospital, Hamburg, Germany
Reduced Reflex Vagal Activity in Patients with AV
Nodal Reentrant Tachycardia Compared to
Patients with Atrioventricular Reentrant
Tachycardia
Lawrence B. Rigden, Raul D. Mitrani. David P. Rardon. Lawrence S. Klein. Douglas
P. Zipes 1, William M. Miles. 1Krannert Institute of Cardiology, Indiana University
School of Medicine, VAMC, Indianapolis, IN
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Fast-slow (Uncommon) Form of Atrioventricular
Nodal Reentrant Tachycardia (AVNRT): New
Classification Based on the Site of the
Retrograde Slow AV Nodal Pathway
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Hiroko Nawata. Naohito Yamamoto, Kazumasa Hiejima, Fumio Suzuki. Internal
Medicine I. Tokyo Medical and Dental University, Tokyo, Japan
During fast-slow (uncommon) form of AVNRT. anterograde conduction oc-
curs over the fast pathway (located at the anterior septum) and retrograde
conduction occurs over the slow pathway (located at the posterior septum).
Thus, in this variety of AVNRT retrograde atrial activation occurs first at or
near the orifice of the coronary sinus (CSOS). then at the low septal right
atrium (LSRA) in the His bundle recording site. However, retrograde slow
pathway may possibly be located at the anterior septum; in such a case. ac-
tivation of the LSRA would be earlier than that of the CSOS. To investigate the
retrograde atrial activation, 12 pts with fast-slow AVNRT (cycle length; 305-
535 ms)were studied while recording the electrograms of the CSOS and the
LSRA.ln addition, to investigate the location of the anterograde fast pathway,
programmed atrial stimulation was done from the CSOS (or proximal CS) and
the anterior high right atrium (HRA) during AVNRT. In all pts reentry using
concealed accessory pathways with long conduction times was excluded.
Results: In 6/12 pts CSOS activation during AVNRT preceded the LSRA ac-
tivation by ~10 ms (posterior type). in 3/12 pts LSRA activation preceded
the CSOS by ~10 ms (anterior type); in the remaining 3 pts (middle type)
those two sites were activated simultaneously (time difference ~5 ms). In
pts with posterior and middle type AVNRT. HRA stimulation during tachycar-
dia preexcited the His bundle and the ventricle via the fast pathway without
capturing the CSOS (i.e .. inter-atrial dissociation) but the dissociation was
not elucidated with CSOS stimulation. indicating that the anterogradely con-
ducting fast pathway is anterior to the retrograde slow pathway. In pts with
anterior AVNRT. CSOS stimulation (but not HRA stimulation) demonstrated
the inter-atrial dissociation. establishing that the anterograde fast pathway
is posterior to the retrograde slow pathway. In 6/6 pts with posterior and 3/3
pts with middle type AVNRT. P waves in inferior leads were deeply negative,
but in 2/3 pts with anterior type AVNRT, P waves were biphasic or shallow.
Conclusions: Fast-slow AVNRT could be divided into 3 types based on the
slow pathway location (posterior, middle Or anteriorl. In anterior type fast-
slow AVNRT. radiofrequency ablation using a posterior approach may fail to
eliminate the slow pathway.
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